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Available online 13 April 2014Abstract Nanog regulates human and mouse embryonic stem (ES) cell self-renewal activity. Activation of ERKs signaling
negatively regulates ES cell self-renewal and induces differentiation, but the mechanisms are not understood. We found that
ERK1 binds and phosphorylates Nanog. Activation of MEK/ERKs signaling and phosphorylation of Nanog inhibit Nanog
transactivation, inducing ES cell differentiation. Conversely, suppression of MEK/ERKs signaling enhances Nanog transactivation to
inhibit ES cell differentiation. We observed that phosphorylation of Nanog by ERK1 decreases Nanog stability through
ubiquitination-mediated protein degradation. Further, we found that this phosphorylation induces binding of FBXW8 with
Nanog to reduce Nanog protein stability. Overall, our results demonstrated that ERKs-mediated Nanog phosphorylation plays an
important role in self-renewal of ES cells through FBXW8-mediated Nanog protein stability.
© 2014 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/3.0/).primal structures in the body that retain two distinctiveIntroduction
Embryonic pluripotent cells can give rise to differentiated
progeny representing all three embryonic germ layers (Pera
et al., 2000). Thus, embryonic stem (ES) cells are special⁎ Corresponding author. Fax: +1 507 437 9606.
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(http://creativecommons.org/licenses/by-nc-nd/3.0/).properties: the ability to self-renew through mitotic cell
division to remain in an undifferentiated state and the
ability to differentiate into a specific cell type (Patel and
Yang, 2010). Stem cell factors, including Oct3/4, Sox2, Klf4,
Nanog, c-Myc and Lin28, are crucial transcription factors
known to regulate ES cells' self-renewal activity and/or to
generate induced pluripotent stem (iPS) cells (Takahashi
et al., 2007; Takahashi and Yamanaka, 2006; Yu et al., 2007).
Nanog occupies a central position in the transcriptional
network of pluripotency (Boyer et al., 2005; Cole et al., 2008;
Loh et al., 2006) and plays an essential role in early embryonic
development (Mitsui et al., 2003). It is expressed in pluripotentis an open access article under the CC BY-NC-ND license
2 S.-H. Kim et al.embryonic cells, derivative ES cells, and the developing germ
line of mammals and birds (Chambers et al., 2003; Lavial et al.,
2007; Mitsui et al., 2003; Yamaguchi et al., 2005). Mouse
Nanog-deficient inner cell mass (ICM) fails to generate
epiblasts and only produces parietal endoderm-like cells
(Mitsui et al., 2003). Conversely, ectopic expression of Nanog
is sufficient to drive leukemia inhibitory factor (LIF; a key
cytokine for maintenance of ES cell pluripotency)-independent
self-renewal of undifferentiated ES cells (Chambers et al.,
2003). Furthermore, 4 factors including Oct3/4, Sox2, Nanog
and Lin28, are sufficient to reprogram human somatic cells to
pluripotent stem cells that exhibit identical and essential
characteristics of ES cells (Yu et al., 2007). Thus, Nanog plays a
central role in ES cell self-renewal in developmental and
de-differentiation processes.
The maintenance of self-renewal and pluripotency in ES
cells is controlled by extrinsic signaling pathways, intrinsic
self-renewal factors and epigenetic modifications (Boiani
and Scholer, 2005; Stewart et al., 2006). LIF, a member of
the IL-6 cytokine family (Smith et al., 1988) provided by
mitotic-inactivated feeder cells, stimulates ES cells through
gp130-JAK-STAT3 signaling (Niwa et al., 1998), resulting in
prevention of ES cell differentiation in the presence of
serum (Matsuda et al., 1999). Besides the activation of
STAT3, LIF also activates mitogen-activated protein (MAP)
kinases, whose activation promotes differentiation of ES
cells in mice (Burdon et al., 1999). Suppression of ERKs
(extracellular-signal regulated kinases) signaling can promote
ES cell self-renewal inmice (Burdon et al., 1999). Thus, mouse
ES (mES) cells might maintain their self-renewal activity in the
presence of LIF due to the balance of STAT3 activation and
ERKs. Also, growth factors, such as LIF and bFGF, activate
the phosphoinositide 3-kinase (PI3-K)/Akt signaling pathway
(Jirmanova et al., 2002) by inhibiting glutathione synthase
kinase 3 β (GSK3β), p53 and Nanog (Takahashi et al., 2003), as
well as suppressing apoptosis in ES cells (Gross et al., 2005). In
contrast to LIF-STAT3 signaling, activation of theWnt pathway
by 6-bromoindirubin-3-oxime (BIO), a specific inhibitor of
GSK3, maintains the undifferentiated phenotype in ES cells
and sustains expression of ES cell specific markers (Sato et al.,
2004) through a synergistic effect with LIF-STAT3 signaling
(Hao et al., 2006). Transforming growth factor beta (TGFβ)/
activin/nodal signaling plays an important role in ES cell
self-renewal. Gene expression analysis indicates that TGFβ
and its correlate factors, including Nodal Cripto Lefty1 and
Lefty 2, are expressed at high levels in undifferentiated
human ES cells (Sato et al., 2003). The TGFβ/activin/nodal
pathway is activated through the Smad2/3 transcription
factors in undifferentiated cells and Smad2/3 activation
suppresses Smad1/5 activity, suggesting that TGFβ/activin/
nodal signaling can negatively regulate bone morphogenetic
protein 4 (BMP4) in human ES cells (Beattie et al., 2005; James
et al., 2005). However, the mechanisms are not understood.
The ubiquitin–proteasome degradation mechanism is asso-
ciated with most intracellular proteins, including membrane-
surface receptors (Gesbert et al., 2005; Martinez-Moczygemba
et al., 2007; Rocca et al., 2001; Wauman et al., 2011). Over
60 Fbox proteins have been identified, but only a few, such
as β-TrCP and FBXW7, are well characterized. Fbox proteins
bind in the substrate-binding motif used for recognition and
interaction with phosphorylated substrates (Kim et al., 2012;
Skowyra et al., 1997).Recent studies indicate that post-translational modifica-
tions of iPS factors regulate their activity. For example,
phosphorylation of human Sox2 at Ser249, Ser250 and Ser
251 (Van Hoof et al., 2009) inhibits Sox2 DNA binding activity
(Tsuruzoe et al., 2006). Acetylation of mouse Sox2 at Lys75
by p300/CBP enhances nuclear export and degradation of
Sox2 through an ubiquitin-mediated degradation pathway
(Baltus et al., 2009). Furthermore, phosphorylation of
human Oct4 at Ser229 by PKA might partially regulate Oct4
transactivation (Baltus et al., 2009). Phosphorylation of
Nanog is associated with Pin1 (Moretto-Zita et al., 2010).
These findings indicate that post-translational modifications
of iPS factors are likely involved in the regulation of their
activity, which could result in modulation of ES cell self-
renewal activity. Herein, we identified mechanisms for the
self-renewal of ES cells showing that regulation of Nanog
protein stability occurs through ERK1-mediated phosphory-
lation and ubiquitination.
Materials and methods
Reagents and antibodies
Dulbecco Modified Eagle's Medium (DMEM) and fetal bovine
serum (FBS) were from Invitrogen (Carlsbad, CA). Restriction
enzymes were obtained from New England BioLabs, Inc.
(Ipswich, MA). The DNA ligation kit (v2.0) was from TaKaRa
Bio, Inc. (Otsu, Shiga, Japan). Lipofectamine 2000 transfec-
tion reagents were obtained from Invitrogen and the JetPEI
transfection reagent for 293 cells was from Q-Biogene (West
Chester, PA). The pcDNA3.1 plasmid was purchased from
Life Technologies, Inc. (Carlsbad, CA). The luciferase assay
substrate was acquired from Promega (Madison, WI). The
monoclonal-HA, His or Flag antibodies were from Sigma-
Aldrich (St. Louis, MO) and Invitrogen, respectively. Anti-
bodies against Nanog, phosphorylated ERKs (Thr202/Tyr204)
and total ERKs were from Abcam (Cambridge, MA) and Cell
Signaling Technology, Inc. (Danvers, MA), respectively. The
antibody to detect phosphorylated Nanog (Ser52) was
produced by Biosynthesis Inc. (Lewisville, TX).
Cell culture
HEK293 and HeLa cells were cultured in DMEM and 10%
heat-inactivated FBS in a 37 °C, 5% CO2 incubator. Cells
were maintained by medium change every other day and
then split at 90% confluence. Mouse ES cells (E14Tg2a) were
maintained on CF-1 feeder cells, which were treated with
mitomycin-C in standard complete ES cell culture medium
supplemented with 15% heat-inactivated ES qualified FBS
(Millipore, Billerica, MA), 0.055 mM β-mercaptoethanol
(Invitrogen), 2 mM L-glutamine, 0.1 mM MEM non-essential
amino acids and 1000 U/mL leukemia inhibitory factor (LIF;
Millipore, Billerica, MA). ES cells were passaged at 70%
confluence on the feeder cells.
Construction of expression vectors
For the mammalian two-hybrid system assay and overex-
pression of Nanog, the open reading frame of mouse Nanog
3ERK1 phosphorylates Nanog to regulate protein stabilitywas amplified and introduced into the pACT mammalian
two-hybrid system vector or pCMV-HA expression vector.
For the GST-fusion protein of Nanog, full length Nanog
(Nanog-1-305) was constructed by PCR-based amplification
and introduced into the pGEX-5X-C vector (Cho et al., 2007).
All constructs were confirmed by restriction enzyme map-
ping and DNA sequencing.
Western blotting
Cells were harvested and disrupted with NP-40 lysis buffer
[150 mM NaCl, 50 mM Tris–HCl pH 7.5, 1% Nonidet P-40, and
Complete Protease Inhibitor Cocktail Tablets (Roche, India-
napolis, IN)] with thawing and freezing. The proteins were
resolved by SDS-PAGE, transferred onto polyvinylidene
difluoride (PVDF) membranes, and target proteins were
visualized using an enhanced chemiluminescence (ECL)
detection kit with specific antibodies.
Mammalian two-hybrid assay
The mammalian two-hybrid (M2H) assay was conducted
according to the manufacturer's instructions (Checkmate
Mammalian Two-Hybrid System assay; Promega). Briefly,
HEK293 cells were maintained in 10% FBS-DMEM, seeded
(2.0 × 104) into 48-well plates, and cultured 18 h before
transfection. Various plasmids, including pACT-Nanog,
pBIND-kinases and pG5-luciferase were combined in the same
molar ratio (1:1:1) and the total amount of DNA was not more
than 100 ng/well. The transfections were performed using
jetPEI following the manufacturer's protocols. For the lucifer-
ase assay, the cells were disrupted by the addition of luciferase
lysis buffer and incubated for 30 min at room temperature with
gentle shaking. The luciferase activity was measured by a
computer-controlled luminometer (Luminoskan Ascent, MTX
Lab, Inc., McLean, VA) with the automatic addition of 100 μL
substrate buffer. The relative firefly luciferase activity was
calculated using the pG5-luciferase basal control and normal-
ized against Renilla luciferase activity, which included the
pBIND vector as an internal control.
Immunoprecipitation assay
The wildtype pCMV-HA-Nanog, pcDNA4-His-ERK1, and pcDNA4-
His-ERK2 plasmids were transfected (as indicated) into HEK293
cells and cultured 36 h. The cells were harvested and disrupted
with NP-40 lysis buffer. Protein binding was confirmed by
immunoprecipitation and Western blotting with specific prima-
ry and HRP-conjugated secondary antibodies as indicated using
an enhanced chemiluminescence (ECL) detection kit.
In vitro kinase assay
Wildtype GST-Nanog, truncated deletion or point mutant
proteinswere used for an in vitro kinase assaywith active ERK1
or ERK2 (Millipore). Reactions were carried out at 30 °C for
30 min in a mixture containing 50 μmol/L unlabeled ATP and
10 μCi of [γ-32P] ATP. The reaction was stopped by adding 6×
SDS sample buffer and samples were boiled and separated by
10% SDS-PAGE and visualized by autoradiography.Nanog activity assay
To examine transactivation of Nanog, E14Tg2a ES cells
(2.0 × 104) were seeded into 48-well plates and cultured
with complete ES medium containing LIF for 18 h before
transfection. The p5xGal4-luciferase and pBIND-Nanog
wildtype, pmu6 pro si-ERK1, or pCDNA4-ERK1 plasmids
were transfected with various combinations of expression
vectors as indicated and cells were cultured for 36 h. The
cells were disrupted with lysis buffer and luciferase activity
was measured. The relative firefly luciferase activity was
normalized against Renilla luciferase activity, which was
obtained by co-transfection of the Renilla luciferase reporter
plasmid (phRL-SV40).
Alkaline phosphatase staining
To stain for colonies, ES cells were cultured in the
appropriate medium, fixed with 2% formalin for 2 min at
room temperature, and then alkaline phosphatase (AP)
staining was performed with the Alkaline Phosphatase
Detection Kit (Millipore) following the manufacturer's pro-
tocols. AP-positive colonies were observed under a light
microscope (Olympus, Center Valley, PA).
RT-PCR and real time
Total RNA was extracted with Trizol reagent (Invitrogen).
One microgram of total RNA was used for the reverse
transcription reaction with the SuperScriptII RT-PCR kit
(Gibco BRL) following the manufacturer's recommendations.
PCR was performed with ExTaq (TaKaRa, Japan). Gene
expression of REX-1, Brachury, FGF5, Sox2, Oct4, and Nanog
was analyzed by polymerase chain reaction (PCR) with gene
specific primers (Supplemental Table 1). Gene expression of
Nanog, Oct4, Sox2, and Brachyury was also analyzed by real
time PCR (Supplemental Table 2).
Protein stability and ubiquitination
To examine Nanog protein stability, E14Tg2a ES cells were
cultured and treated with MG132 and cyclohexamide (CHX).
Cells were harvested and protein levels were visualized by
Western blotting with specific antibodies. Protein levels
were determined at 2, 4, and 6 h after CHX treatment. To
assess ubiquitination, the pcDNA3-Flag-Ub expression vector
was co-transfected into E14Tg2a ES with combinations of
wildtype and mutant Nanog and CA-MEK1, as indicated. Cells
were cultured for 36 h and then proteins were extracted.
Ubiquitination of Nanog proteins was visualized by immuno-
precipitation with a Flag or HA antibody and Western
blotting as indicated using an enhanced chemiluminescence
(ECL) detection kit.
Results
Nanog is a novel substrate of ERK1
Stem cell factors, including Sox2, Nanog, Oct3/4, Myc and
Klf4, play a key role in self-renewal of embryonic stem (ES)
4 S.-H. Kim et al.cells and reprogramming to induced pluripotent stem (iPS)
cells (Takahashi et al., 2007; Takahashi and Yamanaka,
2006; Yu et al., 2007). Recent studies indicate that post-
translational modifications, such as phosphorylation, acety-
lation, ubiquitination and sumoylation of Sox2 and Oct4
modulate their transactivation and/or transcriptional activ-
ity (Baltus et al., 2009; Saxe et al., 2009; Tsuruzoe et al.,
2006; Van Hoof et al., 2009). Thus, we hypothesized that
post-translational modifications, especially phosphoryla-
tion, of Nanog could modulate its activity. To identify
potential kinase(s) of Nanog, we conducted a mammalian
two-hybrid system assay (Cho et al., 2005) and found that
ERK1 showed the highest binding activity with Nanog (Fig. 1A).
To determine whether Nanog is a selective substrate of
ERK1 or ERK2, we conducted an in vitro kinase assay with
[γ-32P] ATP, active ERK1 or ERK2, and GST-Nanog, which
was constructed and purified in our laboratory. The RSK2
N-terminal was used as a positive substrate control for ERK1
and 2. Autoradiography results indicated that ERK1 strongly
phosphorylated Nanog and ERK2 showed only a weak phos-
phorylated band even though ERK1 and ERK2 were used at
identical enzyme units of activity (Fig. 1B). To determine
whether serines 52, 65, 71, and 78 are the target amino acids
of Nanog that are phosphorylated by ERK1, we constructed a
point mutant (serine to alanine) of each in GST-Nanog-1-305
and then purified the proteins and conducted an in vitro kinase
assay with [γ-32P] ATP and active ERK1. We found that the
point mutants S52A, S71A and S78A, but not S65A, exhibited
substantially decreased 32P-labeled band density (Fig. 1C).
Furthermore, we found that the triple mutation of Nanog,
including Ser52, exhibited the most substantially decreased
32P labeled band density (Fig. 1D, lanes 3–5 vs. 2). These
results indicated that activated ERK1 phosphorylates serines
52, 71, and 78, but not 65, on Nanog. Using ectopic expression
and co-immunoprecipitation, we found that ERK1 or 2 and
Nanog interacted in an ex vivo cell culture system (Fig. 1E).Figure 1 Nanog is a novel substrate of ERK1 and ERK1 signaling ne
two-hybrid assay assessment of the ex vivo protein–protein interacti
indicated by relative luminescence units normalized to a negative co
pACT-Nanog = 1.0). Data are shown as means ± S.D. of values obta
evaluated using the Student's t-test (*, p b 0.05, **, p b 0.005). B
phosphorylation of Nanog by ERK1 or ERK2, a GST-Nanog-1-305 fusion
assay with [γ-32P] ATP and active ERK1 or ERK2, and then visualiz
GST fusion protein. C, Confirmation of Nanog phosphorylation
-Nanog-1-305-S71A and -Nanog-1-305-S78A proteins were purified
active ERK1. The phosphorylated bands were visualized by autoradio
65, 78A, -Nanog-1-96-S52, 71, 78A, -Nanog-1-96-S65, 71, 78A an
and subjected to an in vitro kinase assay with [γ-32P] ATP and
autoradiography. E, confirmation of Nanog and ERK1 and ERK2 bindi
pCMV-HA-Nanog-1-305 construct was co-transfected with pcDNA4-H
disrupted with NP-40 lysis buffer and immunoprecipitated with a
detected by Western blot (WB) using an HRP-conjugated HA antibod
The p5xGal4-luciferase reporter plasmid and pGal4-Nanog-1-305-W
gene, were co-transfected with different doses of pmU6si-ERK1 into E
and normalized against Renilla luciferase activity. Data are shown as
significant differences were evaluated using the Student's t-test (
transactivation activity. The p5xGal4-luciferase reporter and pGal
doses of pCDNA4-HisG-ERK1 and cultured for 36 h. The luciferase a
activity. Data are shown as means ± S.D. of values obtained from tr
using the Student's t-test (*, p b 0.005).Overall, these results demonstrated that Nanog is a novel
binding partner and substrate of ERK1.
ERK1 signaling negatively regulates
Nanog transactivation
Stem cell factors, including Nanog, are transcription factors
that regulate gene expression of downstream target genes
involved in stem cell self-renewal and iPS production
(Chambers et al., 2003; Mitsui et al., 2003). To examine the
effect of ERK1 phosphorylation on the transactivation activity
of Nanog, we constructed a pGal4-Nanog expression vector and
analyzed the transactivation activity of Nanog using a
p5xGal4-luciferase reporter assay and knocking down ERK1
expression. Knockdown of ERK1 increased Nanog trans-
activation activity in a dose-dependent manner corresponding
with the dose-dependent decrease in the ectopic expression
level of ERK (Fig. 1F). Furthermore, the transactivation activity
of Nanog was decreased dose-dependently by co-expression of
ERK1 (Fig. 1G). These result indicated that phosphorylation of
Nanog negatively regulates Nanog transactivation activity,
suggesting that the ERK1-Nanog signaling axis might negatively
regulate ES cell self-renewal activity.
ERK1-Nanog signaling modulates self-renewal
activity of ES cells
Recent studies indicated that the MAP kinase signaling
pathway plays an important role in the homeostasis of stem
cell self-renewal activity (Ying et al., 2008). To examine the
relationship between Nanog and ERKs activation in the
differentiation process, we induced differentiation of ES
cells by withdrawal of LIF and confirmed the protein level of
Nanog and phosphorylation level of ERKs. The results indicated
that the Nanog protein level was decreased and ERKsgatively regulates Nanog transactivation activity. A, mammalian
ons of pACT-Nanog and various pBIND–protein kinases. Activity is
ntrol (value for cells transfected with only pG5-luciferase [luc]/
ined from triplicate experiments. Significant differences were
, Nanog is phosphorylated by ERK1 and ERK2. To confirm the
protein was purified and directly subjected to an in vitro kinase
ed by autoradiography. Each asterisk indicates the respective
by ERK1. The GST-Nanog-1-305-S52A, -Nanog-1-305-S65A,
and subjected to an in vitro kinase assay with [γ-32P] ATP and
graphy. D, The GST-Nanog-1-96-S52, 65, 71A, -Nanog-1-96-S52,
d -Nanog-1-96-S52, 65, 71, 78A fusion proteins were purified
active ERK1. The phosphorylated bands were visualized by
ng. To confirm the binding of Nanog with ERK1 and/or ERK2, the
isG-ERK1 into HEK293 cells. After culturing for 36 h, cells were
HisG monoclonal antibody. Co-immunoprecipitated Nanog was
y. F, knockdown of ERK1 induces Nanog transactivation activity.
T plasmid, which also harbors the Renilla luciferase reporter
14 cells and cultured 36 h. The luciferase activity was measured
means ± S.D. of values obtained from triplicate experiments and
*, p b 0.005). G, ectopic expression of ERK1 suppresses Nanog
4-Nanog-1-305-WT plasmids were co-transfected with different
ctivity was measured and normalized against Renilla luciferase
iplicate experiments and significant differences were evaluated
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(Fig. 2A). Additionally, to confirm the localization of Nanog
and phosphorylated ERKs, we induced ES cell differentiation
and treated cells with PD98059 to inhibit ERKs phosphoryla-
tion. The Nanog protein is always localized in both the nucleus
and cytoplasm. Phosphorylated ERKs is also expressed in both
the nucleus and cytoplasm, but translocates to the nucleus
where it is concentrated during ES cell differentiation.
However, PD98059 prevents ERKs phosphorylation and in-
creases Nanog protein level (Supplemental Fig. 1A, B). To
explore ERK1-Nanog signaling in ES cells, we determined the
optimum concentration of LIF needed to obtain the maximum
difference for studying the inhibitory effect of ERKs signaling
induced by PD98059, a MEKs inhibitor. Results indicated
that 10 units of LIF allowed the most gradual differentiation
during the 4 day-differentiation process (Kim et al., 2012).
Therefore, we co-treated ES cells with LIF (10 IU) and various
doses of PD98059 (0, 5, 10, 20 μM). We found that inhibition
of ERKs signaling increased the number of AP-positive
colonies in a dose-dependentmanner (Fig. 2B). Differentiation
markers (i.e., Brachury and FGF5) were substantially sup-
pressed by treatment with PD98059 dose-dependently underFigure 2 ERK1-mediated Nanog phosphorylation plays a critical r
during ES cell differentiation. E14Tg2a ES cells were forced to differ
the indicated time point. The protein levels of Nanog, FBXW8, and ph
β-Actin was used as an internal control to verify equal protein loadi
differentiation. E14Tg2a ES cells were cultured for 4 days in LIF-redu
were fixed and stained using an alkaline phosphatase (AP) staining
counted under a light microscope (×40). C, inhibition of ERKs signalin
cultured for 4 days in LIF-reduced ES medium containing different do
including REX-1, Sox2 and differentiation markers, including brachyu
chain reaction (RT-PCR) with gene specific primers. GAPDH was
D, inhibition of ERKs signaling restores Nanog protein level. E14Tg
containing different doses of PD98059. The proteins were extracte
β-Actin was used as an internal control to verify equal protein loadiLIF-containing conditions (Fig. 2C). Furthermore, non-
differentiation markers, including REX-1, were increased
substantially (Fig. 2C). Transcription of REX-1 is regulated by
Nanog (Shi et al., 2006). Under LIF-withdrawal conditions,
brachery was decreased and Sox2 protein levels were
increased by treatment with PD98059 without changes in
FGF5 or REX-1 (Fig. 2C). We treated ES cells with LIF (10 IU)
and PD98059 (0, 5, 10, 20 μM) and found that ERKs phosphor-
ylation was inhibited by increasing the amount of PD98059 in
complete ES culture medium without altering the total ERKs
protein level. The total protein level of Nanog was increased
dose-dependently by PD98059, suggesting that ERKs might
have a role in stabilizing Nanog (Fig. 2D). These results
indicated that the ERK1-Nanog signaling axis negatively
regulates self-renewal activities during ES cell maintenance.Nanog phosphorylation plays an important role in
protein stability
Previous results indicated that the Nanog protein level was
decreased and phosphorylated ERKs were increased in theole in ES cell self-renewal. A, protein levels of Nanog and ERKs
entiate by withdrawal of LIF and the proteins were extracted at
osphorylated and total ERKs were analyzed by Western blotting.
ng. B, inhibition of ERKs signaling by PD98059 suppresses ES cell
ced ES medium containing different doses of PD98059. The cells
kit. The colonies were observed and AP-positive colonies were
g restores ES cell differentiation markers. E14Tg2a ES cells were
ses of PD98059. Gene expression of non-differentiation markers
ry and FGF5, was analyzed by reverse transcription-polymerase
used as an internal control to verify equal amounts of cDNA.
2a ES cells were cultured for 4 days in LIF-reduced ES medium
d and visualized by Western blotting with specific antibodies.
ng.
Figure 3 Nanog is a novel substrate of FBXW8 and modulates protein degradation through the ubiquitin mediated proteosomal
degradation pathway. A, the Nanog protein level is regulated through the proteosomal degradation pathway. E14Tg2a ES cells were
treated with cyclohexamide (10 μg/mL) with or without MG132 (10 μM), an inhibitor of the proteosomal degradation pathway, and
then proteins were extracted at the indicated time point. The Nanog protein level was visualized by Western blotting using a Nanog
specific antibody. β-Actin was used as an internal control to verify equal protein loading. B, PD98059 inhibits ubiquitination of
exogenous Nanog in ES cells. The indicated combination of expression vectors was co-transfected into E14Tg2a ES cells and cultured
for 36 h in LIF-deficient ES medium. The ubiquitination of Nanog was visualized by immunoprecipitation with anti-HA and Western
blotting with anti-Ub. C, endogenous ubiquitination of Nanog during ES cell differentiation depends on phosphorylated ERK. PD98059
inhibits ubiquitination of endogenous Nanog in ES cells. The ubiquitination of Nanog was visualized by immunoprecipitation
with anti-Nanog and Western blotting with anti-Ub. D, the pcDNA3-Flag-βTrCP1, pcDNA3-Flag-βTrCP2, pcDNA3-Flag-FBXW2,
pcDNA3-Flag-FBXW4, pcDNA3-Flag-FBXW5, pcDNA3-Flag FBXW7α, and pcDNA3-Flag-FBXW8 plasmids were each co-transfected with
pCMV-HANanog-1-305-WT into HEK293 cells and cells cultured for 36 h. The proteins were extracted with NP-40 cell lysis buffer. The
Nanog proteins were immunoprecipitated with anti-HA and the co-immunoprecipitated FBXW4, FBXW5 and FBXW8 proteins were
visualized by Western blotting with anti-Flag. The ectopic protein levels of the Flag-Fbox proteins and HA-Nanog were visualized by
Western blotting with specific antibodies using the same cell lysate. β-Actin was used as an internal control to verify equal protein
loading. E, Nanog mutations at serines 52, 65, 71 and 78 abrogate Fbox protein binding. Combinations of expression vectors, including
HA-Nanog-WT, HA-Nanog-mt, Flag-FBXW4, Flag-FBXW5 and Flag-FBXW8 as indicated, were co-transfected into HEK293 cells and
cultured for 36 h. The proteins were immunoprecipitated with anti-HA and the co-immunoprecipitated Fbox proteins were visualized
by Western blotting using anti-Flag. The ectopic protein levels of Flag-FBXW4, Flag-FBXW5 and Flag-FBXW8 and HA-Nanog were
visualized by Western blotting with specific antibodies using the same cell lysate. β-Actin was used as an internal control to verify
equal protein loading.
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results suggest that the stability of the Nanog protein might
play an important role in the regulation of its activity. To
address this hypothesis, we analyzed protein stability by
treatment with MG132, a proteosomal inhibitor, in either the
presence or absence of cyclohexamide (CHX), an inhibitor of
translation, in ES cells after withdrawal of LIF. We found that
CHX treatment rapidly reduced the Nanog protein level and
MG132 treatment restored the Nanog protein level (Fig. 3A).
Importantly, we further found that the MEK inhibitor, PD98059,
reduced the ubiquitination of Nanog (Fig. 3B). Endogenous
ubiquitination of Nanog was increased during ES cell differen-
tiation and phosphorylated ERKs also increased. Inhibition
of ERKs by PD98059 decreased the ubiquitination of Nanog
(Fig. 3C). These results clearly demonstrated that the Nanog
protein level is regulated by protein stability through ERKs
phosphorylation and phosphorylation of Nanog plays a critical
role in the regulation of Nanog protein stability.FBXW8 is responsible for Nanog stability
The Fbox protein is the substrate-recognition component
among the families of E3 ubiquitin ligases (Nandi et al.,
2006). To identify the E3 ligase responsible for targeting
Nanog, we used immunoprecipitation to screen several Fbox
E3 ligases including β-TrCP1 (FBXW1), β-TrCP2 (FBXW11),
FBXW2, FBXW4, FBXW5, FBXW7α and FBXW8 (Fig. 3D).
Notably, we found that FBXW4, FBXW5 and FBXW8 wereFigure 4 Function of FBXW8 in ES cells. A, E14 cells were introdu
The half-life of endogenous Nanog in control or FBXW8 knockdown
B, ES cells were introduced with lentivirus containing pLK0.1-Mock,
was assessed in control or FBXW8 knockdown cells cultured witho
introduced with pCDNA3-Flag-FBXW8 and the half-life of endogeno
expression enhances stem cell self-renewal activity. The pLK0.1-moc
and then cells were cultured without LIF in ES medium for 3 days, fix
were counted under a light microscope (×40). Data are shown as
Significant differences were evaluated using the Student's t-test (*,co-immunoprecipitated with Nanog (Fig. 3D, lanes 6, 7 and
9). Very importantly, strong binding of wildtype Nanog with
FBXW8 induced by CA-MEK1 was totally abrogated in the
mutant Nanog (Fig. 3E). These results indicated that the
FBXW8 is the most responsible partner for Nanog stability.FBXW8 regulates Nanog stability
To confirm the role of FBXW8, we introduced knockdown
(Supplemental Fig. 2) and overexpression systems (Supple-
mental Fig. 3A, B). Exogenous transcription was dramatically
increased by ectopic expression of FBXW8 and the total level
of FBXW8 transcription was slightly increased (Supplemental
Fig. 3A). Quantitative real time RT-PCR results showed that
endogenous transcription was not changed (Supplemental
Fig. 3B). Knockdown or overexpression of FBXW8 has an
effect on ES cell differentiation. Quantitative real time
RT-PCR results confirmed the effect of FBXW8 on ES cell
markers (Supplemental Fig. 4). Transduction with shFBXW8
substantially extended the half-life of endogenous Nanog
(Fig. 4A) and increased protein stability in ES cell differen-
tiation (Fig. 4B). Further, FBXW8 overexpression shortened
the half-life of endogenous Nanog (Fig. 4C) and alkaline
phosphatase assay results indicated that knockdown of
FBXW8 delayed ES cell differentiation (Fig. 4D). These
results demonstrated that FBXW8 is an E3 ligase that is
responsible for reducing Nanog protein stability, resulting in
ES cell differentiation.ced with lentivirus containing pLK0.1-Mock or pLK0.1-shFBXW8.
cells was assessed using the cyclohexamide (CHX) chase assay.
and pLK0.1-shFBXW8. The protein stability of endogenous Nanog
ut LIF in ES medium for the indicated days. C, ES cells were
us Nanog is shown by Western blot. D, knocking down FBXW8
k or pLK0. 1-FBXW8 lentivirus was introduced into E14Tg2a cells
ed and stained using an AP staining kit. The AP-positive colonies
means ± S.D. of values obtained from triplicate experiments.
p b 0.05).
9ERK1 phosphorylates Nanog to regulate protein stabilityDiscussion
Although the methylation status of gene promoters of stem
cell factors is believed to be a major regulatory mechanism
to govern stem cell self-renewal activity, recent studies
have demonstrated that post-translational modifications,
including phosphorylation, sumoylation and ubiquitination,
of stem cell factors, such as Sox2 and Oct4, might play an
important role in the regulation of transcriptional activity
(Baltus et al., 2009; Saxe et al., 2009; Tsuruzoe et al., 2006;
Van Hoof et al., 2009). Recent studies also indicate that
Nanog, an ES cell-specific homeodomain protein, is required
for the self-renewal of ES cells (Chambers et al., 2003; Mitsui
et al., 2003). Self-renewal and maintenance of pluripotency
of mouse ES cells require leukemia inhibitory factor (LIF; a
member of the IL-6 cytokine family), which is used for
maintenance of ES cells in an undifferentiated state (Smith
et al., 1988; Williams et al., 1988). At the same time, LIF
also stimulates and activates the MAP kinase pathway, the
activation of which induces differentiation of ES cells. How-
ever, suppression of ERKs signaling promotes the self-renewal
activity of mES cells (Burdon et al., 1999). Therefore, the
ERKs signaling pathway is believed to play an important role
in the regulation of ES cell self-renewal activity. In this study,
we found that ERK1, but not ERK2, strongly binds with and
phosphorylates Nanog in vitro (Fig. 1A, B, E). This finding is
important because ERKs signaling induces ES cell differentia-
tion (Burdon et al., 1999) and the MEK inhibitor, PD0325901,
enhances ES cell self-renewal activity (Ying et al., 2008).
Furthermore, our results demonstrated that ERK1 signaling
negatively modulates Nanog transactivation activity (Fig. 1F,
G) and enhances ubiquitination of Nanog (Fig. 3B, C). The
down-regulation of the protein level of Nanog during ES
cell differentiation corresponded with increased levels of
phosphorylated ERKs (Fig. 2A). Therefore, we concluded
that the phosphorylation of Nanog mediated by ERK1 is critical
for the down-regulation of Nanog through ubiquitination-
mediated protein stability. In order to regulate the protein
level through the proteosomal protein degradation pathway,
the binding and interaction of the ubiquitin conjugation
machinery with the target protein are necessary (Hochstrasser,
1996). However, the molecular mechanism explaining how
the phosphorylation of Nanog affects stability is not yet
clearly understood.
Another group identified the same phosphorylation sites in
the Nanog protein (22). However, they did not show a direct
phosphorylation of Nanog but showed that it was phosphory-
lated atmultiple Ser/Thr-Promotifs by an unidentified kinase.
We showed the direct phosphorylation of Nanog by ERK1
(Fig. 1B) and clearly showed that Ser52 is the major phos-
phorylation site and Ser65 is weakly phosphorylated by ERK1
(Fig. 1C, D). Using similar experimental conditions to study
protein stability, we found that phosphorylation of Nanog by
ERK1 resulted in decreased Nanog stability and inhibition of
ERK1 increased stability. In contrast, others found that
phosphorylation of multiple Ser/Thr-Pro motifs increased
Nanog stability (22). This suggests that the exact phosphory-
lation site(s) and/or kinase involved can determine whether
Nanog is stabilized or degraded.
Many transcription factors are involved in ES cell
self-renewal and the regulation of pluripotency. Nanog has
been shown to exhibit auto-regulation (Loh et al., 2006).Although Nanog is a key regulator for ES cell self-renewal
(Ying et al., 2008), a direct mechanism for regulating Nanog
activity has not been elucidated. Our findings demonstrated
that ERK1 is a major direct effector kinase of Nanog (Fig. 1).
We found that activation of ERK1 signaling inhibited trans-
activation activity of Nanog (Fig. 1G). In contrast, blocking
ERK1 signaling by siRNA-ERK increased the transactivation
activity of Nanog (Fig. 1F). The effects further affected
ES cell self-renewal activity (Fig. 2B, C). These results
correspond well with previous studies showing that the
MEKs/ERKs signaling pathway negatively regulates ES cell
self-renewal activity (Burdon et al., 1999). In addition,
quantitative real time RT-PCR results showed that Sox2, but
not Oct4, was affected by FBXW8 directly or indirectly.
However, future studies are needed. A number of transcrip-
tion factors are required for pluripotency of stem cells.
Nanog, a homeobox transcription factor, plays a critical role
in regulating embryonic stem cell pluripotency (Ramakrishna
et al., 2011). Our study has highlighted a degradation
mechanism of Nanog through FBXW8 as a recognition com-
ponent (Fig. 3D, E). Nanog is a novel substrate of FBXW8 in
proteolytic processing by ubiquitin-mediated degradation.
Summary
Our findings demonstrate a molecular mechanism explaining
how ERKs signaling negatively regulates Nanog activity in ES
cells.
Supplementary data to this article can be found online at
http://dx.doi.org/10.1016/j.scr.2014.04.001.
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